Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Intellipharmaceutics International Inc. (Registrant) /s/ Amina Odidi Date: November 23, 2020
Dr. Amina Odidi Acting Chief Financial Officer
lol
Occam's razor:the simplest solution is most likely the right one.
Hanlon's razor:never attribute to malice that which is adequately explained by stupidity.